Rang	Name	Position
1	Prof. Niels C. Riedemann M.D., Ph.D.	Co-Founder, CEO & Executive Director
2	Prof. Renfeng Guo M.D.	Co-Founder, Chief Scientific Officer & Executive Director
3	Dr. Thomas Taapken Ph.D.	Chief Financial Officer
4	Ms. Derval O'Carroll	Senior VP and Global Head of Regulatory Affairs & Compliance
5	Mr. Jan Medina CFA	Head of Investor Relations & VP
6	Mr. Christian Schmid	VP and Head of Legal Affairs & General Counsel
7	Dr. Maria Habel PH.D.	VP, Head of Preclinical R&D and QC
8	Mr. Kofi Boaten	VP and Head of Supply Quality & Clinical Trial Supplies
9	Mr. Peter Hurt Ph.D.	Senior Director and Head of Drug Safety & Pharmacovigiliance
10	Mr. Daniel Vetter	Senior Director & Head of IT

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	TCG Crossover Management, LLC	9,84%	30,31 Mio. USD
2	Suvretta Capital Management, LLC	5,38%	16,58 Mio. USD
3	Spruce Street Capital LP	3,63%	11,19 Mio. USD
4	683 Capital Management LLC	2,25%	6,93 Mio. USD
5	Great Point Partners LLC	2,07%	6,37 Mio. USD
6	Squadron Capital Management LLC	1,36%	4,18 Mio. USD
7	Bank of America Corp	1,34%	4,13 Mio. USD
8	Eversept Partners, LP	0,88%	2,73 Mio. USD
9	Morgan Stanley - Brokerage Accounts	0,80%	2,46 Mio. USD
10	Millennium Management LLC	0,38%	1,19 Mio. USD
11	Marshall Wace Asset Management Ltd	0,38%	1,16 Mio. USD
12	T3 Companies, LLC	0,22%	0,69 Mio. USD
13	Squarepoint Ops LLC	0,20%	0,63 Mio. USD
14	DCF Advisers, LLC	0,16%	0,48 Mio. USD
15	Two Sigma Investments LLC	0,12%	0,38 Mio. USD
16	ADAR1 Capital Management LLC	0,11%	0,33 Mio. USD
17	Quadrature Capital Limited	0,11%	0,33 Mio. USD
18	Citadel Advisors Llc	0,09%	0,29 Mio. USD
19	Kestra Advisory Services, LLC	0,06%	0,20 Mio. USD
20	XTX Topco Ltd	0,06%	0,19 Mio. USD